Showing results (151-160 of 3,046) with videos related to
Sort By:
Pageof 305
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|October 15, 2010
[Features of acupuncture randomised controlled trials published in the top four journals]Hui Zheng, Fan-rong Liang, Ying LiSurvey Methodology|August 15, 2009
Optimal sample allocation for design-consistent regression in a cancer services survey when design variables are known for aggregatesAlan M Zaslavsky, Hui Zheng, John AdamsAmerican Sociological Review|August 21, 2012
Variance Function Regression in Hierarchical Age-Period-Cohort Models: Applications to the Study of Self-Reported HealthHui Zheng, Yang Yang, Kenneth C LandInorganic Chemistry|February 1, 2005
Iron Coordination Chemistry of Phenylpyruvate: An Unexpected kappa3-bridging mode that leads to oxidative cleavage of the C2-C3 bondTapan K Paine, Hui Zheng, Lawrence QueJournal of Virology|January 10, 2014
The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathwayTao Zhou, Ying Dang, Yong-Hui ZhengJournal of Diabetes Science and Technology|December 7, 2010
Efficacy determinants of subcutaneous microdose glucagon during closed-loop controlSteven J Russell, Firas H El-Khatib, David M Nathan, et al.Diabetes Care|September 28, 2002
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring StudyJames B Meigs, David M Nathan, Ralph B D'Agostino, et al.Diabetes Care|April 24, 2025
The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health ImpactJill P Crandall, Dana Dabelea, William C Knowler, et al.Diabetes|January 29, 2008
Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisitedJohn M Lachin, Saul Genuth, David M Nathan, et al.The New England Journal of Medicine|February 10, 2000
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy, John M Lachin, Saul Genuth, et al.Pageof 305